Deal Library / Pharma BD Deal Intelligence

Mylan Laboratories Inc. — Pharma Deals

The Pharma Closeout tracks 4 deals, $12.2B in disclosed deal value, 3 with a post-close Outcome Score for Mylan Laboratories Inc..

Median Critic Score: 73  ·  Median Outcome Score: 66

Best outcome: Mylan Laboratories Inc. / Merck Generics (Merck KGaA) (81)  ·  Weakest outcome: Mylan Laboratories Inc. / Matrix Laboratories Limited (39)

All 4 deals

• Mylan Laboratories Inc. / Merck Generics (Merck KGaA) — 2007 · $6.7B · Worked — the deal delivered on its rationale.
• Mylan Laboratories Inc. / Matrix Laboratories Limited — 2006 · $736M · Largely worked — most objectives met.
• Mylan Laboratories Inc. / Matrix Laboratories Limited — 2005 · $736M · Underwhelmed — fell short of the thesis.
• Mylan Laboratories Inc. / King Pharmaceuticals Inc. — 2004 · $4.0B

← Deal Library  ·  Interactive search  ·  How we score deals